Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Vascular Biology

Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury

Yi Shi, Rodica Niculescu, Dian Wang, Sachin Patel, Kelly L. Davenpeck, Andrew Zalewski
Download PDF
https://doi.org/10.1161/01.ATV.21.5.739
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:739-745
Originally published May 1, 2001
Yi Shi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodica Niculescu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dian Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachin Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly L. Davenpeck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Zalewski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Abstract—Reactive oxygen species (ROS), produced by cellular constituents of the arterial wall, provide a signaling mechanism involved in vascular remodeling. Because adventitial fibroblasts are actively involved in coronary remodeling, we examined whether the changes in the redox state affect their phenotypic characteristics. To this end, superoxide anion production and NAD(P)H oxidase activity were measured in porcine coronary arteries in vivo, and the effect of ROS generation on adventitial fibroblast proliferation was examined in vitro. Superoxide production (SOD- and Tiron-inhibitable nitro blue tetrazolium [NBT] reduction) increased significantly within 24 hours after balloon-induced injury, with the product of NBT reduction present predominantly in adventitial fibroblasts. These changes were NAD(P)H oxidase–dependent, because diphenyleneiodonium (DPI) abolished superoxide generation (P<0.001). Furthermore, the injury-induced superoxide production was associated with augmented NAD(P)H oxidase activity and upregulation of p47phox and p67phox in adventitial fibroblasts (immunohistochemistry). Serum stimulation of isolated adventitial fibroblasts produced time-dependent increases in ROS production (peak 3 to 6 hours). The inhibition of ROS generation with NAD(P)H oxidase inhibitor (DPI) or the removal of ROS with antioxidants (Tiron, catalase) abrogated proliferation of adventitial fibroblasts. These results indicate that vascular NAD(P)H oxidase plays a central role in the upregulation of oxidative stress after coronary injury, providing pivotal growth signals for coronary fibroblasts.

  • reactive oxygen species
  • NAD(P)H oxidase
  • coronary remodeling
  • adventitial fibroblast
  • Received December 4, 2000.
  • Accepted January 8, 2001.

Oxidative stress has been implicated in several steps leading to the development of vascular disease.1 2 Initial observations focused on reactive oxygen species (ROS) derived from invading macrophages and their possible involvement in oxidative lipid modifications in the vessel wall. Subsequently, it has become apparent that ROS are also produced in a controlled fashion by all vascular cells and that they act as “second messengers” regulating various cellular functions. Several extracellular signals, such as growth factors or even physical stimuli, induce ROS and their derivatives in vascular smooth muscle cells (SMCs) and fibroblasts, activating the intracellular growth program.3 4 5 6 For example, superoxide anion (·O2−) increases expression of extracellular signal–regulated kinase 1/2 mitogen-activated protein kinase, whereas H2O2 activates p38 mitogen-activated protein kinase and stress-activated proteins.7 8 Furthermore, H2O2 also stimulates early proto-oncogenes and redox-sensitive transcriptional factors (eg, NF-κB and AP-1).9

In vascular cells, the major enzymatic source of intracellular ROS is NAD(P)H oxidase, which generates ·O2− by 1-electron reduction of molecular oxygen.10 11 12 Although NADPH oxidase is responsible for the burst of ·O2− in phagocytic cells, the generation of ROS in vascular cells differs from that in neutrophils. In the former, it occurs over a period of hours (rather than minutes), appears to be mostly intracellular (rather than extracellular and intracellular), and may involve the assembly of different enzymatic subunits of NAD(P)H oxidase.13 Significant progress has been made toward the identification of NAD(P)H oxidase subunits in normal vascular cells and in atherosclerotic lesions, including both membrane-associated (p22phox) and cytoplasmic (p67phox, p47phox, Rac1) components.6 14 15 16 The activity of the NAD(P)H oxidase in vascular cells is modulated by extracellular signals known to influence vascular remodeling and lesion development (eg, thrombin and angiotensin II).6 15 16 17 Furthermore, gene polymorphism affecting at least one of the subunits (p22phox) has been linked to the development of atherosclerosis in humans.18 19

The regulation of the redox state appears to be heterogeneous across the vessel wall. Higher expression of NAD(P)H oxidase and ·O2− production have been reported in normal adventitia than in the media.20 21 The importance of this finding initially remained unclear, because the activation of medial SMCs and lipid peroxidation occur in the proximity of the arterial lumen. Several studies from our laboratory and others, however, have suggested active involvement of adventitial fibroblasts in arterial repair.22 23 24 In particular, after severe coronary injury, these cells demonstrate preferential proliferation and migration toward intima. This is not surprising, because coronary SMCs display more advanced differentiation and a limited response to stimulation compared with noncoronary SMCs.25 26 In view of our previous findings and the established role of ROS in the regulation of cell proliferation, we hypothesized that the increase in oxidative stress after coronary injury involves adventitial fibroblasts. The results of this study demonstrated the upregulation of NAD(P)H oxidase activity and ROS production in adventitial fibroblasts after coronary injury. In cell culture, ROS are important signals for growth response of coronary fibroblasts. We postulate that phenotypic responsiveness of coronary fibroblasts to stimulation is mediated, in part, by NAD(P)H oxidase–derived oxidative stress.

Methods

Animal Model

Domestic crossbred female pigs (12 to 15 kg) were anesthetized and instrumented as previously described.22 23 After the exposure of the right common carotid artery, heparin (5000 U) was administered intravenously. Coronary ostia were cannulated under fluoroscopic guidance, and intracoronary nitroglycerin was given (100 μg). Coronary injury was carried out in 2 coronary arteries in each animal with an oversized balloon (balloon:artery ratio ≈1.3 to 1.5) inflated 2 to 3 times for 30 seconds. The third artery was used as control. The animals were euthanatized with intravenous Euthasol (Delmarva Laboratory) at times indicated in the text. All experiments were carried out in accordance with institutional guidelines.

Measurement of ·O2− Production

The production of ·O2− was measured by superoxide dismutase (SOD)– or Tiron-inhibitable conversion of nitro blue tetrazolium (NBT) to formazan.20 21

·O2− Production in Coronary Arteries

Coronary arteries were dissected free from adipose tissue and myocardium, then cut into ≈5-mm rings and placed in 24-well plates. Tissues were balanced in phenol-free DMEM at 37°C in a CO2 incubator for 30 minutes with or without addition of ·O2− SOD (1000 U/mL) or Tiron (10 mmol/L). Freshly made NBT (100 mg/L in phenol-free DMEM) was added to tissues with gentle rocking for 3 hours. The reaction was terminated by addition of an equal volume of 0.5N HCl, and tissues were rinsed twice with cold PBS. To extract formazan, tissues were pulverized in liquid nitrogen and dissolved in 100% pyridine at 80°C for 30 minutes. After centrifugation, light absorbance was read in supernatants at 540 nm. The NBT reduction to formazan was calculated by the following formula: NBT reduction=A×V/(T×E×L), where A is absorbance, V is volume of solubilizing solution, T is time of incubation with NBT (minutes), E is extinction coefficient=0.72 mmol/mm, and L is length of light travel through the solution, 10 mm. Either SOD- or Tiron-inhibitable NBT reduction was calculated as a measure of ·O2− production (pmol · min−1 · mg wet wt−1). To determine pathways mediating ·O2− production, several inhibitors were used in the experiments, including diphenyleneiodonium (DPI, 100 μmol/L), rotenone (50 μmol/L), oxypurinol (300 μmol/L), Nω-nitro-l-arginine methyl ester (L-NAME, 1 mmol/L), and diethyldithiocarbamic acid (10 mmol/L). The n value represents the number of vascular rings obtained from ≥3 animals per experimental condition.

To assess the location of injury-induced ·O2− production, the injured coronary arteries were incubated with NBT and processed to visualize formazan deposits. Briefly, coronary rings were fixed in 10% formalin and embedded in paraffin. They were sectioned into 6-μm-thick sections and deparaffinized by heating at 65°C for 1 hour. To avoid solubilization of NBT in tissue, the sections were rinsed with Clear-Rite 3 solution (Richard-Allan Scientific) and counterstained with nuclear fast red.

·O2− Production in Isolated Adventitial Fibroblasts

Adventitial fibroblasts (passages 2 through 6) were plated in 6-well plates at 100 000 cells/well in 10% FBS. At 2 days later, when cells were ≈80% confluent, they were arrested in 0.5% FBS for the next 48 hours. After that, they were stimulated with 10% FBS for 1 to 24 hours, followed by incubation with NBT (0.5 mg/mL in phenol-free DMEM) for 1 hour. After brief washing, cells were trypsinized and cell pellets were dissolved in 100% pyridine. The light absorbance was measured at 540 nm and the NBT reduction to formazan was calculated as described above and corrected by cell number. Values were derived from 6 to 9 wells from 3 separate experiments.

Measurement of NAD(P)H Oxidase Activity in Coronary Arteries

NAD(P)H oxidase activity was measured by SOD-inhibitable cytochrome c reduction using NADH or NADPH as substrate.17 To measure NAD(P)H oxidase activity in injured coronary arteries, the arteries were harvested at 2 days after injury, and the injured segments (including the adventitia and media) were dissected free from adipose tissue and myocardium. The noninstrumented coronary arteries were used as control. After the removal of endothelial cells, tissues were minced in 10 volumes of ice-cold Tris-sucrose buffer (pH 7.1) containing Tris base 10 mmol/L, sucrose 340 mmol/L, PMSF 1 mmol/L, EDTA 1 mmol/L, leupeptin 10 μg/mL, aprotinin 10 μg/mL, and pepstatin 10 μg/mL. Then the tissue homogenates were sonicated for 20 seconds on ice, followed by extraction for 30 minutes. After centrifugation at 15 000g for 10 minutes, an aliquot (20 μL) of supernatant (50 to 150 μg of protein) was added to the reaction buffer (980 μL) containing cytochrome c (78 μmol/L), NADH, or NADPH (100 μmol/L), with or without SOD (1000 U/mL). The samples were then incubated at 37°C for 1 hour, and the absorbance at 550 nm was measured. There was no measurable activity in absence of NADH. A buffer blank was measured in each assay, and SOD-inhibitable cytochrome c reduction in buffer blank was subtracted from each sample. The activity of NAD(P)H oxidase was calculated as SOD-inhibitable cytochrome c reduction and expressed as ·O2− in pmol · mg−1 · min−1.

Measurement of SOD Activity in Coronary Arteries

SOD activity in vascular tissues was measured by SOD-dependent inhibition of cytochrome c reduction catalyzed by xanthine/xanthine oxidase.27 To assess SOD activity in uninjured coronary arteries, coronary adventitia and media were dissected after the removal of endothelium. SOD activity after coronary injury was measured in arterial segments including the adventitia and media. The tissues were minced and homogenized in 10 volumes of 50 mmol/L potassium phosphate (pH 7.4) containing 0.3 mol/L KBr and a cocktail of protease inhibitors (0.5 mmol/L PMSF, 90 μg/mL aprotinin, 10 μg/mL pepstatin, 10 μg/mL leupeptin). After sonication for 20 seconds, the homogenates were extracted at 4°C for 30 minutes, followed by centrifugation at 15 000g for 10 minutes. The supernatants were added to the reaction mixture consisting of 0.1 mmol/L EDTA, 0.090 mmol/L xanthine, and 0.018 mmol/L cytochrome c (pH 7.4). SOD activity was assessed by monitoring the inhibition of xanthine oxidase–mediated cytochrome c reduction, with the absorbance measured at 550 nm over 3 minutes.

Immunohistochemistry

The Vectastain Elite ABC system (Vector Laboratories) was used for immunohistochemistry as previously described.22 28 Sections were deparaffinized, incubated with 0.6% H2O2 in methanol for 30 minutes, and blocked with 5% horse or rabbit serum. After being washed in PBS, sections were incubated with primary antibodies for 1 hour at room temperature in a moisture chamber. The following primary antibodies were used: polyclonal antibodies against p47phox and p67phox (1:200, Santa Cruz), monoclonal antibody recognizing SM myosin heavy chain (SM-MHC, 1:800, Sigma), and porcine macrophages (1:10, ATCC HB 142). Then slides were washed and incubated with biotinylated secondary horse anti-mouse or rabbit anti-goat antibodies (1:2000, Vector Laboratories) for 1 hour. They were visualized with DAB substrate (Vector Laboratories) followed by counterstain with Gill’s hematoxylin (Sigma Diagnostics). Negative controls were carried out with nonimmune serum instead of primary antibody.

Cell Proliferation Assay

Fibroblasts were isolated from the adventitia of porcine coronary arteries as described.26 The cells (passages 2 to 6) were plated in triplicate at 10 000 cells/well in 24-well plates in DMEM supplemented with 10% FBS. At 24 hours later, cells were arrested in DMEM containing 0.5% FBS for 48 hours. They were then stimulated with 10% FBS for 3 days with or without addition of indicated inhibitors. Cells were trypsinized at 72 hours after stimulation and counted in a Coulter counter. Values were derived from 3 wells per treatment, and the experiments were repeated ≥3 times on separate occasions.

Statistical Analyses

Data were expressed as mean±SD. The statistical significance regarding multigroup comparisons was determined by ANOVA with Bonferroni correction. A value of P<0.05 was considered significant.

Results

Oxidative Stress in Normal and Injured Coronary Arteries

Normal Coronary Arteries

Normal coronary adventitia exhibited higher basal ·O2− generation (4.4±1.2 pmol · mg−1 · min−1 SOD-inhibitable NBT reduction) than did the media (0.4±0.5 pmol · mg−1 · min−1, n=6, P<0.01). As shown in Figure 1⇓, the preincubation of coronary rings with DPI [NAD(P)H oxidase inhibitor] abolished ·O2− production in coronary adventitia, whereas rotenone (mitochondrial dehydrogenase inhibitor) and oxypurinol (xanthine oxidase inhibitor) had no effect. The difference in basal ·O2− generation between coronary adventitia and media is probably due to heterogeneous distribution of endogenous SOD, inasmuch as adventitia exhibited lower SOD activity than did media (101±7 versus 166±9 U/g, P<0.001, n=5). Subsequently, SOD inhibitor (diethyldithiocarbamic acid) augmented more ·O2− generation in the media (adventitia 19.6±2.5 and media 36.3±8.2 pmol · mg−1 · min−1, P<0.01 versus no diethyldithiocarbamic acid).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Superoxide anion (·O2−) generation in coronary adventitia and media in control (uninjured) arteries. The adventitia showed a higher basal level of ·O2− production than the media (SOD-inhibitable NBT reduction). An NAD(P)H oxidase inhibitor, DPI, inhibited ·O2− generation in coronary adventitia, whereas oxypurinol (OXY) and rotenone (ROT) showed no inhibitory effects. The lack of SOD-inhibitable NBT reduction in boiled adventitia further confirmed an enzymatic source of ·O2− production. *P<0.001 vs coronary media; †P<0.001 vs coronary adventitia without treatment (n=6 to 9 vascular rings per bar).

Injured Coronary Arteries

Because coronary injury induces a short-lived adventitial cell proliferation, the change in oxidative stress during this time period was examined. To this end, the SOD activity and ·O2− generation were measured in the entire coronary segments, because precise separation of the adventitia from media is not technically feasible at early time points after injury. SOD activity showed no difference between control and injured coronary segments (not shown). ·O2− generation, as measured by SOD- and Tiron-inhibitable NBT reduction, increased significantly within 1 day after injury, and it remained elevated for ≥10 days (Figure 2⇓). Higher values of Tiron-inhibitable NBT reduction were probably due to better cellular permeability of Tiron than SOD. To ascertain the site of ·O2− generation in injured vessels, reduced NBT (formazan) was identified in cross sections. Figure 3⇓ demonstrates preferential adventitial localization of intracellular deposits of formazan in injured segments. As in uninjured vessels, NAD(P)H oxidase inhibitor (DPI) almost entirely abolished the production of ·O2− after coronary injury (n=4 per time point, P<0.001 versus no treatment). Although dynamic changes in inducible nitric oxide synthase expression during coronary repair could contribute to oxidative stress, its inhibitor, L-NAME, showed no effect (Table 1⇓).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

The time course of ·O2− production after coronary injury. The ·O2− production (SOD- and Tiron-inhibitable NBT reduction) was measured in transmural segments of uninjured and injured vessels. The increase in ·O2− generation was observed within 1 day after injury. *P<0.05 and †P<0.01 vs uninjured coronary arteries. Numbers represent the number of vascular rings.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Localization of superoxide in injured coronary arteries. Injured coronary arteries (2 days) were incubated with NBT for 3 hours and processed for NBT histology. A, Cross section of injured coronary artery with apparent site of injury. The areas of the adventitia (a) and media (m) outlined by rectangular boxes are depicted at higher magnification. B, Intracellular deposits of formazan (blue) were present in adventitial cells in the center of injury. C, Coronary medial SMCs showed no intracellular formazan deposits despite medial dissection. Magnification: A ×40, B and C ×410.

View this table:
  • View inline
  • View popup
Table 1.

NAD(P)H Oxidase–Dependent Superoxide Generation in Injured Coronary Arteries

NAD(P)H Oxidase Activity and Expression of Subunits

NAD(P)H Oxidase Activity

To ascertain that NAD(P)H oxidase is the major pathway responsible for oxidative stress after coronary injury, NADH/NADPH oxidase activity was measured by SOD-inhibitable cytochrome c reduction using NADH or NADPH as substrates. At baseline, coronary arteries exhibited similar levels of NADH and NADPH oxidase activity. At 2 days after coronary injury, NADH oxidase activity was significantly augmented in the injured and adjacent segments (Table 2⇓), whereas NADPH oxidase activity showed no changes after coronary injury.

View this table:
  • View inline
  • View popup
Table 2.

NAD(P)H Oxidase Activity in Injured Coronary Arteries

Expression of p47phox and p67phox

To localize NAD(P)H oxidase in injured coronary arteries, expression of p47phox and p67phox [cytoplasmic subunits of NAD(P)H oxidase] were examined by immunohistochemistry. They were low in normal coronary arteries (not shown) but showed a marked increase in adventitial cells after injury. The expression began at 1 day and peaked at 2 days after injury. Positive cells were of fibroblastic origin, because they lacked SM differentiation markers (SM-MHC, α-SM actin, desmin, and caldesmon), and only infrequent cells (<5%) were positive for macrophage immunoreactivity (Figure 4⇓).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Localization of NAD(P)H oxidase subunits in injured coronary arteries. A, Cross section of injured coronary artery stained for SM-MHC. At 2 days after injury, coronary medial SMCs exhibited a strong SM-MHC immunoreactivity, whereas adventitial cells were negative. The areas of the adventitia (a) and media (m) outlined by rectangular boxes are depicted at higher magnification. B, Injured adventitia contained mostly replicating fibroblasts with only infrequent macrophages. C, The majority of activated adventitial cells exhibited increased immunoreactivity for p47phox. D, Coronary media showed no increase in p47phox immunoreactivity. E, Likewise, p67phox is increased in adventitial cells, but not in the media (not shown). F, Negative control (NC; primary antibody was omitted). Magnification: A ×40, B through E ×410.

Role of NAD(P)H Oxidase–Derived ROS Production in Coronary Fibroblast Proliferation

Serum-Induced Superoxide Production in Adventitial Fibroblasts

To assess the functional importance of increased oxidative stress in coronary adventitia, the ·O2− production was examined in serum-stimulated adventitial fibroblasts. In response to serum stimulation, adventitial fibroblasts demonstrated a time-dependent increase in ·O2− production, reaching maximum levels at 3 to 6 hours (Figure 5⇓). As expected, either the inhibition of NAD(P)H oxidase with DPI (10 μmol/L) or dismutation of ·O2− with exogenous SOD (500 U/mL) produced significant reduction in ·O2− production (Figure 6⇓), whereas L-NAME, rotenone, and oxypurinol showed no effects (not shown).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Serum-induced ·O2− generation in coronary fibroblasts. Adventitial fibroblasts were plated in 6-well plate at 100 000 cells/well in 10% FBS for 2 days. The cells were growth-arrested with 0.5% FBS for 48 hours, followed by stimulation with 10% FBS. The NBT was added to cells for 1 hour, and intracellular accumulation of formazan was measured. Adventitial fibroblasts demonstrated a time-dependent ·O2− production peaking at 6 hours after stimulation (n=9 per time point). *P<0.001 vs no stimulation.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Inhibition of serum-induced ·O2− generation in coronary fibroblasts. Adventitial fibroblasts were pretreated with DPI (10 μmol/L) or SOD (500 U/mL) for 30 minutes, followed by stimulation with 10% FBS for 3 hours. The cells were then incubated with NBT for 1 hour, and the inhibition of formazan accumulation was measured. Both DPI and SOD showed significant inhibition of ·O2− production (n=4 per treatment). *P<0.001 vs 10% FBS.

Serum-Induced Superoxide Generation and Adventitial Fibroblast Proliferation

To assess whether altering ROS generation could modulate adventitial fibroblast proliferation in vitro, growth inhibition of serum-stimulated cells was determined either by inhibiting the generation of ROS (DPI) or facilitating their removal (·O2−: Tiron, SOD; and H2O2: catalase). The inhibitor of NAD(P)H oxidase (DPI) significantly inhibited fibroblast growth in a concentration-dependent manner (Figure 7⇓, P<0.001). In contrast, L-NAME and oxypurinol produced no significant effects (not shown), consistent with the lack of inhibition of ROS generation by these inhibitors. The removal of either ·O2− with Tiron or H2O2 with catalase inhibited fibroblast proliferation. In contrast, dismutation of ·O2− to H2O2 after SOD did not prevent serum-induced cell replication.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

ROS and adventitial fibroblast proliferation. Adventitial fibroblasts (10 000 cells/well) were arrested with 0.5% FBS for 48 hours and then stimulated with 10% FBS in presence of various inhibitors. Cell growth was examined at 3 days after treatment by cell counting. The inhibitor of NAD(P)H oxidase (DPI), the scavenger of ·O2− (Tiron), or the removal of H2O2 (catalase) significantly inhibited fibroblast growth in a concentration-dependent manner. In contrast, dismutation of ·O2− to H2O2 with SOD showed no significant inhibition of fibroblast proliferation. *P<0.05 and †P<0.01 vs 10% FBS alone (n=3 per bar). The experiments were repeated 3 times, yielding similar results.

Discussion

The major findings of this study were that (1) coronary adventitia is an important source of increased oxidative stress after endoluminal coronary injury, (2) the NAD(P)H oxidase is the major pathway for ROS generation in injured coronary arteries and stimulated adventitial fibroblasts, and (3) ROS are involved in the regulation of growth response of coronary adventitial fibroblasts.

Oxidative stress is known to increase after various forms of vascular insult.6 29 30 Although the presence of NAD(P)H oxidase has been shown in normal adventitia,16 20 21 its role in cellular proliferation during arterial repair has not previously been elucidated. In noncoronary vasculature, there is a rapid decrease in glutathione level, an indirect marker of the redox state, after mechanical injury.30 Others have reported the induction of p47phox, thus implicating NAD(P)H oxidase and ROS generation in initial SMC proliferation.6 Likewise, p22phox expression and oxidative stress are increased in aortic medial SMCs after angiotensin II infusion.31 Unique characteristics of coronary SMCs, however, raise the question of whether similar events occur during coronary repair.25 26 Earlier studies showed an increase in ·O2− production at 2 weeks after coronary injury, although the presence of the neointima, containing cells of adventitial and medial origin, blood-borne cells, and regenerating endothelial cells, did not allow for the identification of its source.29 To characterize the mechanism of oxidative stress and its role in cellular proliferation, the present study focused on earlier stages of coronary response to injury, with cellular constituents still remaining at their sites of origin. Predominant increases in ROS generation and vascular NAD(P)H oxidase (p47phox and p67phox subunits) were evident in the adventitia (Figures 3⇑ and 4⇑). In contrast, coronary media exhibited higher levels of SOD and subsequently lower oxidative stress. It remains to be determined whether the degree of SMC differentiation, which differs among vascular beds, contributes to regional differences in the activation of NAD(P)H oxidase and ROS generation after injury. The inhibition of NAD(P)H oxidase with DPI or the removal of ROS (·O2− and H2O2 with Tiron or H2O2 with catalase) abrogated serum-induced growth response of isolated coronary fibroblasts in vitro (Figure 7⇑). Not surprisingly, dismutation of ·O2− to H2O2 after SOD was ineffective in preventing cell replication, pointing to the essential role of H2O2 in the regulation of vascular cell growth.3 The above findings suggested the involvement of ROS in a rapid proliferation of adventitial fibroblasts after coronary injury in vivo.22 23 24 The relatively slow and prolonged ROS production in adventitial fibroblasts (Figure 5⇑) was similar to that in noncoronary SMCs but quite distinct from the faster and greater response previously seen in phagocytes.32 Preferential utilization of NADH as substrate for NAD(P)H oxidase in injured coronary arteries contrasts with the observations by others that aortic adventitial fibroblasts primarily generate ·O2− in response to NADPH.12 21 Several experimental conditions (eg, cell origin and type of stimulation), as well as assay methods (eg, cytochrome c reduction versus lucigenin assay) may be responsible for these differences.33

The increase in oxidative stress stimulates cell growth, but ROS can also cause cellular death (reviewed by Griendling and Harrison).34 It is likely that these opposite results are related to the level and the type of ROS (·O2− versus H2O2).35 36 Much less is known, however, regarding the consequences of oxidative stress in vascular cells with a broad range of differentiation. When terminally differentiated cardiomyocytes and interstitial fibroblasts were exposed to H2O2, apoptosis was induced in the former and proliferation in the latter.37 Although endoluminal injury in a porcine model did not significantly enhance intracellular ROS generation in coronary media, extracellular oxidative stress may impact SMC survival. In chronic intimal lesions, inflammatory cells, particularly active in the generation of oxidative stress, have been shown to contribute to SMC apoptosis.38 The loss of differentiated coronary SMCs may lead to a decrease of a protective barrier of the intact media, resulting in the expansion of less differentiated fibroblasts and the development of intimal lesions. Our results support the notion that ROS production may serve as an attractive target for therapeutic interventions. Nevertheless, several questions remain unresolved, including the choice of antioxidants, because negative clinical results with vitamin E.39 In contrast, 2 independent clinical studies suggested a reduction in coronary restenosis in patients pretreated with the antioxidant probucol before angioplasty.40 41 The recently published Heart Outcomes Prevention Evaluation (HOPE) trial also provided evidence for the reduction of cardiovascular mortality after chronic administration of the ACE inhibitor ramipril.42 These results are particularly notable because NAD(P)H oxidase activity is regulated by angiotensin II.10 15 21 Undoubtedly, better understanding of the regulation of NAD(P)H oxidase in different vascular cells may provide further insights into the pathogenesis of coronary artery disease and aid the development of therapeutic interventions.

In conclusion, this study demonstrated an increase in NAD(P)H oxidase–derived ·O2− production in coronary adventitial fibroblasts after balloon injury. The inhibition of NAD(P)H oxidase and the attenuation of ROS production abrogated proliferative responses of adventitial fibroblasts. The results imply that ROS serve as pivotal signals for growth response of coronary fibroblasts.

Acknowledgments

This study was supported by National Institutes of Health grants HL-44150 and HL-60672.

References

  1. ↵
    Griendling KK, Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med. 1998;132:9–15.
    OpenUrlCrossRefPubMed
  2. ↵
    Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753–766.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296–299.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Zafari MA, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor RW, Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II–induced vascular hypertrophy. Hypertension. 1998;32:488–495.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Hishikawa K, Oemar BS, Yang Z, Lüscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res. 1997;81:797–803.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. J Biol Chem. 1999;274:19814–19822.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. P38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022–15029.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Baas AS, Berk BC. Differential activation of mitogen-activated protein kinases by H2O2 and O2− in vascular smooth muscle cells. Circ Res. 1995;77:29–36.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70:593–599.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Griendling KK, Minieri CA, Ollerenshaw D, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141–1148.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Mohazzab-H KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568–H2572.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Pagano PJ, Tornheim YK, Gallop PM, Tauber AI, Cohen RA. A NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995;268:H2274–H2280.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Suh Y, Arnold RS, Lassègue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generation oxidase Mox1. Nature. 1999;401:79–82.
    OpenUrlCrossRefPubMed
  14. ↵
    Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, Yoloyama M. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation. 1999;100:1494–1498.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Ushio-Fukai M, Zafari M, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317–23321.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 1998;32:331–337.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T. Increased NADH-oxidase–mediated superoxide production in the early stage of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 1999;99:2027–2033.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation. 1998;97:135–137.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res. 2000;86:391–395.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, Cohen RA. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998;82:810–818.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A. 1997;94:14483–14488.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Shi Y, Pieniek M, Fard A, O’Brien J, Mannion JD, Zalewski A. Adventitial remodeling following coronary arterial injury. Circulation. 1996;93:340–348.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Shi Y, O’Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655–1664.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178–2187.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, van Eys G, Gabbiani G. Cultured porcine coronary artery smooth muscle cells: a new model with advanced differentiation. Circ Res. 1999;85:99–107.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Patel S, Shi Y, Niculescu R, Chung EH, Martin JL, Zalewski A. Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation. 2000;101:524–532.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Fukai T, Galis Z, Meng XP, Parthasarathy S, Harrison DG. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998;101:2101–2111.
    OpenUrlCrossRefPubMed
  28. ↵
    Shi Y, O’Brien JE Jr, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95:997–1006.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Nunes GL, Robinson K, Kalynych A, King SB III, Sgoutas DS, Berk BC. Vitamins C and E inhibit O2− production in the pig coronary artery. Circulation. 1997;96:3593–3601.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ Res. 1999;84:113–121.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45–51.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Bokoch GM. Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteins. Curr Opin Cell Biol. 1994;6:212–218.
    OpenUrlCrossRefPubMed
  33. ↵
    Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494–501.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Griendling KK, Harrison DG. Dual role of reactive oxygen species in vascular growth. Circ Res. 1999;85:562–563.
    OpenUrlFREE Full Text
  35. ↵
    Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, Patterson C, Perrella MA, Cook C, Wang H, Haber E, Schlegel R, Lee ME. Induction of apoptosis by pyrrolidinedithiocarbamate and N acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667–3670.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Brown MR, Miller F, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engehardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res. 1999;85:524–533.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Li PF, Dietz R, von Harsdorf R. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-β1 in cardiac fibroblasts. FEBS Lett. 1999;448:206–210.
    OpenUrlCrossRefPubMed
  38. ↵
    Kockx MM, Guido RY, Meyer D, Bortier H, de Meyere N, Muhring J, Bakker A, Jacob W, Vaeck LV, Herman A. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 1996;94:1255–1262.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342:154–160.
    OpenUrlCrossRefPubMed
  40. ↵
    Tardif JC, Còté G, Lespérance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997;337:365–372.
    OpenUrlCrossRefPubMed
  41. ↵
    Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, Nakata Y, Kutsumi Y, Ohshima S, Nishiyama S, Seki A, Kato K, Nishimura S, Kanoh T, Yamaguchi H. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol. 1997;30:855–862.
    OpenUrlCrossRefPubMed
  42. ↵
    The Heart Outcomes Prevention Evaluation Study Investigators. Effects of angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
May 2001, Volume 21, Issue 5
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury
    Yi Shi, Rodica Niculescu, Dian Wang, Sachin Patel, Kelly L. Davenpeck and Andrew Zalewski
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:739-745, originally published May 1, 2001
    https://doi.org/10.1161/01.ATV.21.5.739

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury
    Yi Shi, Rodica Niculescu, Dian Wang, Sachin Patel, Kelly L. Davenpeck and Andrew Zalewski
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:739-745, originally published May 1, 2001
    https://doi.org/10.1161/01.ATV.21.5.739
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Heart Failure and Cardiac Disease
    • Remodeling
  • Vascular Disease
    • Restenosis
  • Genetics
    • Gene Expression & Regulation
  • Basic, Translational, and Clinical Research
    • Oxidant Stress
    • Cell Signaling/Signal Transduction

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • Instructions for Authors
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured